Cardiac troponin I (cTnI) is considered as a gold standard for diagnostic of acute myocardial infarction (AMI) and myocardial infarction (MI). The biomarker is released into blood stream during cardiac event. In high-sensitivity cTnI test can be suitable to rule out MI and to identify a low-risk group of patients who may avoid unnecessary hospital admissions and increase the patient care in emergency departments.
HyTest offers 5 new antibodies specific for cTnI. The antibodies are specific to epitopes 22-40 (Y306 and Y503), 83-100 (Y101), 161-178 (Y501), and 174-191 (Y502). The new clones can be found under Cat.# 4T21cc and RC4T21. All the antibodies can be used for quantitative cTnI immunoassay development. Recommended pairs for the new clones is presented in the table 1.
Table 1. Pair recommendations for the new anti-cTnI antibodies.
Cat# 4T21cc: Troponin I cardiac (cTnI), antibody
Cat# RC4T21: Recombinant anti-cardiac troponin I (cTnI)